Adverse Drug Reaction Clinical Trials

3 recruiting

Adverse Drug Reaction Trials at a Glance

9 actively recruiting trials for adverse drug reaction are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Bryan, Vancouver, and Basel. Lead sponsors running adverse drug reaction studies include Texas A&M University, University of British Columbia, and Luke Bereznicki.

Browse adverse drug reaction trials by phase

Treatments under study

About Adverse Drug Reaction Clinical Trials

Looking for clinical trials for Adverse Drug Reaction? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adverse Drug Reaction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adverse Drug Reaction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System

Adverse Drug Reaction (ADR)
University of British Columbia150 enrolled2 locationsNCT04249375
Recruiting

National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children

Adverse Drug Reaction (ADR)
University of British Columbia7,000 enrolled1 locationNCT00414115
Recruiting

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

CancerCOPDDiabetes+6 more
Texas A&M University3,000 enrolled1 locationNCT06726590
Recruiting

The Texas Interprofessional Pharmacogenomics (IPGx)

Adverse Drug Reaction
Texas A&M University50 enrolled1 locationNCT06219720
Recruiting
Not Applicable

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Adverse Drug Reaction (ADR)EffectivenessMental Disorder+1 more
University of Manitoba200 enrolled2 locationsNCT06929533
Recruiting

Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure

Adverse Drug ReactionTherapy Failure
University Hospital, Basel, Switzerland400 enrolled1 locationNCT04154553
Recruiting

IPGx PILOT Whole Genome Sequencing Extension Cohort

Adverse Drug Reaction (ADR)Polypharmacy Patients
Texas A&M University50 enrolled1 locationNCT06766071
Recruiting

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

Adverse Drug EventDrug UseDrug Side Effect+3 more
Universidade do Porto150 enrolled3 locationsNCT06498167
Recruiting

Preventing Adverse Drug Reactions in Older Australians

ElderlyAdverse drug reactions
Luke Bereznicki1,000 enrolled1 locationACTRN12619000729123